Aebersold DM - Search Results

1

Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial.

Ghadjar P, Hayoz S, Bernhard J, Zwahlen DR, Hölscher T, Gut P, Polat B, Hildebrandt G, Müller AC, Plasswilm L, Papachristofilou A, Schär C, Sumila M, Zaugg K, Guckenberger M, Ost P, Reuter C, Bosetti DG, Khanfir K, Gomez S, Wust P, Thalmann GN, Aebersold DM; Swiss Group for Clinical Cancer Research (SAKK). Ghadjar P, et al. Among authors: aebersold dm. Eur Urol. 2021 Sep;80(3):306-315. doi: 10.1016/j.eururo.2021.05.033. Epub 2021 Jun 14. Eur Urol. 2021. PMID: 34140144 Clinical Trial.

2

Expression of transforming growth factor-alpha, epidermal growth factor receptor and platelet-derived growth factors A and B in oropharyngeal cancers treated by curative radiation therapy.

Aebersold DM, Froehlich SC, Jonczy M, Beer KT, Laissue J, Greiner RH, Djonov V. Aebersold DM, et al. Radiother Oncol. 2002 Jun;63(3):275-83. doi: 10.1016/s0167-8140(02)00131-7. Radiother Oncol. 2002. PMID: 12142091

3

Prevalence and clinical impact of Met Y1253D-activating point mutation in radiotherapy-treated squamous cell cancer of the oropharynx.

Aebersold DM, Landt O, Berthou S, Gruber G, Beer KT, Greiner RH, Zimmer Y. Aebersold DM, et al. Oncogene. 2003 Nov 20;22(52):8519-23. doi: 10.1038/sj.onc.1206968. Oncogene. 2003. PMID: 14627992

4

Applicability and dosimetric impact of ultrasound-based preplanning in high-dose-rate brachytherapy of prostate cancer.

Aebersold DM, Isaak B, Thalmann G, Behrensmeier F, Kolotas C, Kranzbühler H, Mini R, Greiner RH. Aebersold DM, et al. Strahlenther Onkol. 2004 Jun;180(6):351-7. doi: 10.1007/s00066-004-1225-2. Strahlenther Onkol. 2004. PMID: 15175869 Clinical Trial.

5

Daily organ tracking in intensity-modulated radiotherapy of prostate cancer using an electronic portal imaging device with a dose saving acquisition mode.

Vetterli D, Thalmann S, Behrensmeier F, Kemmerling L, Born EJ, Mini R, Greiner RH, Aebersold DM. Vetterli D, et al. Among authors: aebersold dm. Radiother Oncol. 2006 Apr;79(1):101-8. doi: 10.1016/j.radonc.2006.03.005. Epub 2006 Apr 18. Radiother Oncol. 2006. PMID: 16621076

6

Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking.

Ghadjar P, Vock J, Vetterli D, Manser P, Bigler R, Tille J, Madlung A, Behrensmeier F, Mini R, Aebersold DM. Ghadjar P, et al. Among authors: aebersold dm. Radiat Oncol. 2008 Oct 20;3:35. doi: 10.1186/1748-717X-3-35. Radiat Oncol. 2008. PMID: 18937833 Free PMC article.

7

Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy.

Ghadjar P, Keller T, Rentsch CA, Isaak B, Behrensmeier F, Stroux A, Thalmann GN, Aebersold DM. Ghadjar P, et al. Among authors: aebersold dm. Brachytherapy. 2009 Jan-Mar;8(1):45-51. doi: 10.1016/j.brachy.2008.09.004. Epub 2008 Nov 26. Brachytherapy. 2009. PMID: 19038584

8

Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer.

Ghadjar P, Matzinger O, Isaak B, Behrensmeier F, Stroux A, Rentsch CA, Thalmann GN, Aebersold DM. Ghadjar P, et al. Among authors: aebersold dm. Radiother Oncol. 2009 May;91(2):237-42. doi: 10.1016/j.radonc.2008.12.007. Epub 2009 Jan 21. Radiother Oncol. 2009. PMID: 19167121

9

The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer.

Ghadjar P, Rubie C, Aebersold DM, Keilholz U. Ghadjar P, et al. Among authors: aebersold dm. Int J Cancer. 2009 Aug 15;125(4):741-5. doi: 10.1002/ijc.24468. Int J Cancer. 2009. PMID: 19480006 Free article. Review.

10

MET Y1253D-activating point mutation and development of distant metastasis in advanced head and neck cancers.

Ghadjar P, Blank-Liss W, Simcock M, Hegyi I, Beer KT, Moch H, Aebersold DM, Zimmer Y. Ghadjar P, et al. Among authors: aebersold dm. Clin Exp Metastasis. 2009;26(7):809-15. doi: 10.1007/s10585-009-9280-9. Epub 2009 Jul 29. Clin Exp Metastasis. 2009. PMID: 19639388 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

215 results

Search Page